News

Grayling is involved in manufacturing various brands for the asbestos abatement and remediation industry including Avail glove bags, D-Con decontamination enclosures, and Control chemicals. The acquisition is expected

The agreement allows miRagen to gain a non-exclusive license to the miRNA therapeutics field and global rights to develop and commercialize LNA drugs targeting six additional microRNAs. Santaris

HyCryo media, a serum-free, animal component-free product, is intended for cryogenic preservation and storage of standard cell lines, while HyCryo-STEM, which is designed for stem cell applications, enhances

Developed by Affymax, the FDA-approved OMONTYS is a synthetic, pegylated erythropoiesis-stimulating agent (ESA) that is peptide-based and its building blocks (amino acids) are arranged in a different order

Takeda Canada and Paladin will co-promote the allergy vaccine product indicated for the treatment of allergic rhinitis due to ragweed pollen for the first eight months prior to

As per the deal, NewVac gains exclusive rights to develop and commercialize Janssen’s quisinostat in Russia and other Eastern European countries. NewVac board chairman Nikolay Savchuk said the

The acetylcysteine injection, which is a generic equivalent of Cumberland Pharmaceuticals’ Acetadote injection, is indicated as an antidote to prevent or lessen hepatic injury that occurs following the

Lomitapide, an orphan drug designed for the treatment of a rare disease caused by a genetic disorder, is expected to be launched in January 2013. Previously, scientists of

Single dose of the pneumococcal conjugate vaccine is used for active immunization against pneumonia and acute otitis media caused by vaccine-type Streptococcus pneumonia in individuals falling under expanded